Document is current

Article History

Received: 5 August 2024

Accepted: 20 January 2025

First Online: 12 February 2025

Declarations

:

: There was no direct participation of human subjects, and the study did not require ethics approval.

: Not applicable.

: The results presented in this paper have not been published previously in whole or part. KG, VB, HK, and AA are employees of Boehringer Ingelheim. PS is a contractor with BIX, the developer of Exandra. JG reports speaking honoraria and has served on an advisory board for Astra Zeneca, Amgen, Abbott, Dexcom, Eli Lilly, Boehringer Ingelheim, Janssen, GSK, HLS therapeutics, Novartis, Pfizer, Novo Nordisk, and Sanofi. SJ reports consulting and/or speaking honoraria from Abbott, Boehringer Ingelheim, Dexcom, Eisai, GSK, Kenvue, Eli Lilly, Moderna, Novo Nordisk, and Pfizer.